TriSalus Life Sciences Ownership | Who Owns TriSalus Life Sciences?


OverviewRevenueFinancialsChartTranscripts

TriSalus Life Sciences Ownership Summary


TriSalus Life Sciences is owned by 8.66% institutional investors, 54.73% insiders, and 36.61% retail investors. Wealthcare advisory partners is the largest institutional shareholder, holding 2.43% of TLSI shares.

TLSI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTriSalus Life Sciences8.66%54.73%36.61%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryMedical Device Stocks40.18%9.93%49.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wealthcare advisory partners643.74K2.43%$3.23M
Blackrock funding, inc. /de30.27K0.11%$151.65K
Vestcor23.38K0.09%$117.00K
State street20.20K0.08%$101.20K
Gilder gagnon howe14.42K0.05%$72.24K
Signaturefd100.000.00%$501.00
Walleye capital---
Two sigma securities---
Magnetar financial---
Virtu financial---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Wealthcare advisory partners643.74K0.09%$3.23M
Vestcor23.38K0.00%$117.00K
Gilder gagnon howe14.42K0.00%$72.24K
Walleye capital---
Virtu financial---
Hrt financial lp---
Signaturefd100.00-$501.00
Magnetar financial---
Blackrock funding, inc. /de30.27K-$151.65K
Two sigma securities---

Top Buyers

HolderShares% AssetsChange
State street20.20K-9.10K
Signaturefd100.00--
Wealthcare advisory partners643.74K0.09%-
Vestcor23.38K0.00%-
Blackrock funding, inc. /de30.27K--

Top Sellers

HolderShares% AssetsChange
Virtu financial---19.88K
Hrt financial lp---15.57K
Walleye capital---14.38K
Magnetar financial---14.23K
Two sigma securities---10.19K

Sold Out

HolderChange
Two sigma securities-10.19K
Magnetar financial-14.23K
Walleye capital-14.38K
Hrt financial lp-15.57K
Virtu financial-19.88K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202425-19.35%2,295,2895.72%812.90%7-50.00%8-11.11%
Sep 30, 20243119.23%2,171,19021.63%814.69%1416.67%9-
Jun 30, 2024268.33%1,785,09892.78%747.37%12-14.29%980.00%
Mar 31, 20242426.32%925,99736.26%37.59%14-5400.00%
Dec 31, 202319111.11%679,602397.60%7672.98%1455.56%1-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 05, 2025Young James Emmett Chief Financial OfficerBuy$33.90K
Jan 30, 2025Szela Mary T CEO AND PRESIDENTBuy$26.45K
Jan 29, 2025Szela Mary T CEO AND PRESIDENTBuy$25.30K
Jan 27, 2025Szela Mary T CEO AND PRESIDENTBuy$26.16K
Jan 28, 2025Szela Mary T CEO AND PRESIDENTBuy$24.15K

Insider Transactions Trends


DateBuySell
2025 Q18-
2024 Q442
2024 Q341
2024 Q2--
2024 Q1--

TLSI Ownership FAQ


Who Owns TriSalus Life Sciences?

TriSalus Life Sciences shareholders are primarily institutional investors at 8.66%, followed by 54.73% insiders and 36.61% retail investors. The average institutional ownership in TriSalus Life Sciences's industry, Medical Device Stocks, is 40.18%, which TriSalus Life Sciences falls below.

Who owns the most shares of TriSalus Life Sciences?

TriSalus Life Sciences’s largest shareholders are Wealthcare advisory partners (643.74K shares, 2.43%), Blackrock funding, inc. /de (30.27K shares, 0.11%), and Vestcor (23.38K shares, 0.09%). Together, they hold 2.63% of TriSalus Life Sciences’s total shares outstanding.

Does Blackrock own TriSalus Life Sciences?

BlackRock is not among the top 10 institutional shareholders of TriSalus Life Sciences.

Who is TriSalus Life Sciences’s biggest shareholder by percentage of total assets invested?

Wealthcare advisory partners is TriSalus Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.09% of its assets in 643.74K TriSalus Life Sciences shares, valued at 3.23M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools